Last reviewed · How we verify
Placebo of Baloxavir Marboxil tablets
Placebo of Baloxavir Marboxil tablets is a Small molecule drug developed by Jiaxing AnDiCon Biotech Co.,Ltd. It is currently in Phase 3 development for Control arm in Phase 3 clinical trials of Baloxavir Marboxil for influenza treatment or prophylaxis.
This is a placebo control formulation with no active pharmacological mechanism.
This is a placebo control formulation with no active pharmacological mechanism. Used for Control arm in Phase 3 clinical trials of Baloxavir Marboxil for influenza treatment or prophylaxis.
At a glance
| Generic name | Placebo of Baloxavir Marboxil tablets |
|---|---|
| Sponsor | Jiaxing AnDiCon Biotech Co.,Ltd |
| Modality | Small molecule |
| Therapeutic area | Virology/Influenza |
| Phase | Phase 3 |
Mechanism of action
As a placebo of Baloxavir Marboxil, this formulation contains no active drug substance and serves as a control arm in clinical trials. Baloxavir Marboxil itself is a cap-dependent endonuclease inhibitor that blocks viral polymerase function, but the placebo formulation is inert and produces no therapeutic effect.
Approved indications
- Control arm in Phase 3 clinical trials of Baloxavir Marboxil for influenza treatment or prophylaxis
Common side effects
Key clinical trials
- Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza (PHASE3)
- Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households (PHASE3)
- A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A (NA)
- Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (PHASE3)
- A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Baloxavir Marboxil tablets CI brief — competitive landscape report
- Placebo of Baloxavir Marboxil tablets updates RSS · CI watch RSS
- Jiaxing AnDiCon Biotech Co.,Ltd portfolio CI
Frequently asked questions about Placebo of Baloxavir Marboxil tablets
What is Placebo of Baloxavir Marboxil tablets?
How does Placebo of Baloxavir Marboxil tablets work?
What is Placebo of Baloxavir Marboxil tablets used for?
Who makes Placebo of Baloxavir Marboxil tablets?
What development phase is Placebo of Baloxavir Marboxil tablets in?
Related
- Manufacturer: Jiaxing AnDiCon Biotech Co.,Ltd — full pipeline
- Therapeutic area: All drugs in Virology/Influenza
- Indication: Drugs for Control arm in Phase 3 clinical trials of Baloxavir Marboxil for influenza treatment or prophylaxis
- Compare: Placebo of Baloxavir Marboxil tablets vs similar drugs
- Pricing: Placebo of Baloxavir Marboxil tablets cost, discount & access